A judge is expected to sentence OxyContin maker Purdue Pharma to forfeit $225 million to the Justice Department on Tuesday, paving the way for the company to finalize settlements in the thousands of lawsuits it faces over its role in the opioid crisis. As part of a 2020 agreement, this penalty acknowledges the company's previous legal shortcomings, including a guilty plea to federal criminal charges, wherein Purdue admitted to improper practices that allowed its powerful prescription painkillers to be diverted for illegal use.
The expected $225 million forfeiture may not be the end of Purdue's legal obligations; however, it is a significant step in resolving the extensive legal challenges linked to the opioid epidemic, which has claimed nearly a million lives in the U.S. since 1999. In a broader settlement, Purdue intends to pay $7 billion to government authorities, specifically aimed to address the ongoing crisis.
Despite this development, many victims and their families are pushing for deeper accountability, expressing concerns that the settlement does not address their personal losses adequately. As Purdue's actions and the Sackler family's financial movements are scrutinized, the legal community awaits to see how this unfolding situation continues to develop.
The expected $225 million forfeiture may not be the end of Purdue's legal obligations; however, it is a significant step in resolving the extensive legal challenges linked to the opioid epidemic, which has claimed nearly a million lives in the U.S. since 1999. In a broader settlement, Purdue intends to pay $7 billion to government authorities, specifically aimed to address the ongoing crisis.
Despite this development, many victims and their families are pushing for deeper accountability, expressing concerns that the settlement does not address their personal losses adequately. As Purdue's actions and the Sackler family's financial movements are scrutinized, the legal community awaits to see how this unfolding situation continues to develop.
